These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1319129)

  • 1. The contribution of steroids to digoxin-like immunoreactivity in cord blood.
    Yun WS; Ho CS; Panesar NS; Swaminathan R
    Ann Clin Biochem; 1992 May; 29 ( Pt 3)():337-42. PubMed ID: 1319129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+, K+-ATPase.
    Diamandis EP; Papanastasiou-Diamandi A; Soldin SJ
    Clin Biochem; 1985 Feb; 18(1):48-55. PubMed ID: 2985294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension.
    Seccombe DW; Pudek MR; Nowaczynski W; Humphries KH
    Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.
    Yiannakou L; Loucari-Yiannakou E; Souvatzoglou A
    Clin Biochem; 1991 Dec; 24(6):475-82. PubMed ID: 1773487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period.
    Seccombe DW; Pudek MR; Humphries KH; Matthewson B; Taylor GP; Jacobson BE; Whitfield MP
    Biol Neonate; 1989; 56(3):136-46. PubMed ID: 2553137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
    Guédeney X; Chanez C; Grenier A; Scherrmann JM
    Clin Chem; 1991 Nov; 37(11):1900-4. PubMed ID: 1718632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like immunoreactive substance in urine of patients with mucocutaneous lymph node syndrome (MCLS).
    Tamura H; Shimoyama S; Sunaga Y; Sakaguchi M; Kuroume T
    Angiology; 1992 Oct; 43(10):856-65. PubMed ID: 1335703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.
    Balzan S; Montali U; Genovesi-Ebert A; Biver P; Fantoni M; Ghione S
    Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
    De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
    Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-like immunoreactive substance in nonoliguric hyperkalemia of the premature infant.
    Mildenberger E; Oels K; Bauer K; Paul M; Versmold HT
    Biol Neonate; 2003; 83(3):182-7. PubMed ID: 12660435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic activity of digoxin-like immunoreactive substance extracted from cord blood.
    Ebara H; Suzuki S; Nagashima K; Kuroume T
    Life Sci; 1988; 42(3):303-9. PubMed ID: 2826960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.
    Bertrand JM; Langhendries JP; Gras A; Battisti O
    Eur J Pediatr; 1987 Mar; 146(2):145-6. PubMed ID: 3032639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits.
    Pudek MR; Seccombe DW; Jacobson BE; Humphries K
    Clin Chem; 1985 Nov; 31(11):1806-10. PubMed ID: 4053349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal changes in a digoxin-like immunoreactive substance.
    Seccombe DW; Pudek MR; Whitfield MF; Jacobson BE; Wittmann BK; King JF
    Pediatr Res; 1984 Nov; 18(11):1097-9. PubMed ID: 6514436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
    Dodds HM; Norris RL; Johnson AG; Pond SM
    Ther Drug Monit; 1995 Feb; 17(1):68-74. PubMed ID: 7725380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatographic characterization of endogenous digoxin-like immunoreactive substances present in serum and urine of infants using gel filtration with Sephadex G 25.
    Clerico A; Boldrini A; Balzan S; Biver P; Fantoni M
    Biol Neonate; 1985; 47(4):217-22. PubMed ID: 3995104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.